Cite
Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations
MLA
Z, Kuzbari, et al. “Germline-Focused Analysis of Tumour-Detected Variants in 49,264 Cancer Patients: ESMO Precision Medicine Working Group Recommendations.” Annals of Oncology, vol. 34, Mar. 2023, pp. 215–27. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ff765a5346fd311ae520e0d112a204fb&authtype=sso&custid=ns315887.
APA
Z, K., C, B., C, L., A, G., M, M., A, G., H, H., K, S., A, K., S, A., S, J., R, F., C B, W., E, C., J, R., J, M., G J, B., M F, B., D, M., & C, T. (2023). Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations. Annals of Oncology, 34, 215–227.
Chicago
Z, Kuzbari, Bandlamudi C, Loveday C, Garrett A, Mehine M, George A, Hanson H, et al. 2023. “Germline-Focused Analysis of Tumour-Detected Variants in 49,264 Cancer Patients: ESMO Precision Medicine Working Group Recommendations.” Annals of Oncology 34 (March): 215–27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ff765a5346fd311ae520e0d112a204fb&authtype=sso&custid=ns315887.